ESSA Pharma to Present at Oppenheimer Annual Healthcare Conference
ESSA Pharma Inc. (NASDAQ: EPIX) will present at the virtual Oppenheimer 32nd Annual Healthcare Conference on March 17, 2022, at 2:40 p.m. ET.
Sentiment and the balance of points
Rhea-AI Sentiment reads the wording of the document, how positive or negative its language is on a 1 to 5 scale. The balance of points shown with the takes weighs what the document actually discloses, so the two can disagree, for example when a trial that missed its main goal is described in upbeat language.
Rhea-AI Summary
ESSA Pharma Inc. (NASDAQ: EPIX) will present at the virtual Oppenheimer 32nd Annual Healthcare Conference on March 17, 2022, at 2:40 p.m. ET. David R. Parkinson, President and CEO, alongside COO Peter Virsik and CFO David S. Wood, will engage in one-on-one meetings during the event. ESSA focuses on developing innovative therapies for prostate cancer. A webcast of the presentation will be available on the company's website and archived for 90 days following the event.
Details
News Market Reaction – EPIX
The recorded move for EPIX in the trading session of this news was -3.64%.
Data tracked by StockTitan Argus. Session date unavailable.
AI-generated analysis. How Rhea-AI works. Not financial advice.
South San Francisco, California and Vancouver, Canada, March 10, 2022 /PRNewswire/ - ESSA Pharma Inc. ("ESSA", or the "Company") (NASDAQ: EPIX), a clinical-stage pharmaceutical company focused on developing novel therapies for the treatment of prostate cancer, today announced that the Company will be presenting at the virtual Oppenheimer 32nd Annual Healthcare Conference on Thursday, March 17, 2022 at 2:40 p.m. Eastern Time.
David. R. Parkinson, President and Chief Executive Officer of ESSA Pharma, will participate in and host one-on-one meetings. Peter Virsik, ESSA's Chief Operating Officer, and David S. Wood, ESSA's Chief Financial Officer, will also be participating in the one-on-one meetings.
Presentation Details
Presentation Date: Thursday, March 17, 2022
Presentation Time: 2:40 p.m. ET
About ESSA Pharma Inc.
ESSA is a clinical-stage pharmaceutical company focused on developing novel and proprietary therapies for the treatment of patients with prostate cancer. For more information, please visit www.essapharma.com and follow us on Twitter under @ESSAPharma.
A webcast of the presentation can be accessed in the Investors/Events & Presentations section of ESSA's website at www.essapharma.com. Following the presentation, the webcast will be archived for 90 days.
View original content:https://www.prnewswire.com/news-releases/essa-pharma-to-present-at-oppenheimer-annual-healthcare-conference-301499623.html
SOURCE ESSA Pharma Inc
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.